Vaccines
Bluevac-3
Inactivated bluetongue virus, serotype 3, strain BTV-3/NET2023
Available in:
- 100mls vial
Cattle
For active immunisation of cattle to reduce the viraemia against the serotype 3 of the bluetongue virus.
Onset of immunity: 21 days after completion of the primary vaccination scheme.
Duration of immunity: not established yet.
No negative impact on milk in lactating cows expected
Sheep
For active immunisation of sheep to reduce the viraemia, preventing mortality and to reduce clinical signs caused by the serotype 3 of the bluetongue virus.
Onset of immunity: 21 days after completion of the primary vaccination scheme.
Duration of immunity: not established yet.
Fertility: The safety and efficacy of the vaccines has not been established in breeding males (sheep and cattle).
Target species:
-
Cattle
-
Sheep
Product information
Download product info
Share this product
How to use
Administration – Subcutaneous use.
- Primary vaccination, can be used during pregnancy in ewes and cows.
- Cattle from 2 month of age: Administer two doses of 4 ml subcutaneously 3 weeks apart
- Sheep from 2 months of age: Administer two doses of 2 mL subcutaneously 3 weeks apart
- Revaccination not yet established
- Withdrawal: Zero days
Prescription decisions are for the person issuing the prescription alone. Please refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications. Further information is available from the SPC or on the datasheet or on request.
Legal Category: UK POMV
Why choose
Bluevac
In cattle Bluevac-3
Reduces the viraemia (the presence of virus in the blood)
In sheep Bluevac-3
Reduces the viraemia, preventing mortality and reduces clinical signs caused by the serotype 3 of the bluetongue virus
Convenience
Can be administered during pregnancy to ewes and female cattle
Pack options
No negative impact on milk in lactating cows expected. Zero milk and meat withdrawal.